Physiologically relevant 3D tumor models for therapeutic screening
Biomaterials · 2026-11 · 334 · 124231
DOI: 10.1016/j.biomaterials.2026.124231 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomaterials, 2026-11. Verfasst von Renjian Xie und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Disease (Ministry of Education), School of Medical and Information E…. Hauptthemen laut MEDLINE: Neoplasms, Antineoplastic Agents, Models, Biological. Die Arbeit nennt 280 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Institute of Dental and Craniofacial Research, National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Abstract (Originalsprache)
The heterogeneity of the tumor microenvironment poses a significant challenge to the success of anti-cancer therapeutics. Consequently, there is an urgent need to generate comprehensive data to elucidate the mechanisms underlying tumor resistance and to inform the rational and systematic application of anti-cancer drugs to mitigate drug resistance. In-vitro tumor models based on established cell lines are widely employed in studying the mechanisms of action of drugs; however, these traditional models often fail to accurately recapitulate the complexity of native tumors, particularly in terms of the heterogenous and intricate tumor microenvironment, including cellular composition, intercellular communication, and interactions between cells and extracellular matrix. As a result, preclinical data often diverges from clinical outcomes. In recent years, the emergence of patient-derived three-dimensional (3D) models including spheroids, organoids, tumor-on-a-chip systems, and 3D bioprinting has offered promising alternatives for addressing these limitations and enhancing the predictive power of tumor drug screening. In this review, we explore the relationship between the complexity of the tumor microenvironment, tumor drug resistance, and then introduce the current biofabrication techniques enabling the reconstruction of 3D tumor models in vitro. We delve deeper into a myriad of applications of such models for a wide range of cancer indications. These models offer a morfailures andlly relevant platform for evaluating anti-cancer drugs with the potential to improve translational accuracy, reduce drug development failures, and accelerate the discovery of cancer therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Disease (Ministry of Education), School of Medical and Information Engineering, Gannan Medical University, Ganzhou, Jiangxi, 341000, China…
- Strand Therapeutics Inc., Boston, MA, 02215, USA.
- Engineering Science and Mechanics Department, Penn State, University Park, PA, 16802, USA.
- Engineering Science and Mechanics Department, Penn State, University Park, PA, 16802, USA; Department of Biomedical Engineering, Penn State, University Park, PA, 16802, USA; Department of Neurosurgery, Penn State, Hersh…
Förderung
- National Natural Science Foundation of China
- National Institute of Dental and Craniofacial Research
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Jiangxi Provincial Natural Science Foundation
- Major Discipline Academic and Technical Leaders Training Program of Jiangxi Province
Zitieren
APA
Xie, R., Yang, J., Lu, X., Liu, F., Dey, M., Kaur, N., Peng, W., & Ozbolat, I. T. (2026). Physiologically relevant 3D tumor models for therapeutic screening. Biomaterials, 334, 124231. https://doi.org/10.1016/j.biomaterials.2026.124231
Vancouver
Xie R, Yang J, Lu X, Liu F, Dey M, Kaur N, et al. Physiologically relevant 3D tumor models for therapeutic screening. Biomaterials. 2026;334:124231. doi:10.1016/j.biomaterials.2026.124231
BibTeX
@article{Xie2026,
author = {Xie, Renjian and Yang, Jianqiong and Lu, Xiaolu and Liu, Fang and Dey, Madhuri and Kaur, Navneet and Peng, Weijie and Ozbolat, Ibrahim T},
title = {Physiologically relevant 3D tumor models for therapeutic screening},
journal = {Biomaterials},
year = {2026},
volume = {334},
pages = {124231},
doi = {10.1016/j.biomaterials.2026.124231}
}
EUVIMED